The 'runner's high' — the euphoric state of wellbeing, reduced pain perception, and emotional transcendence reported by some endurance athletes — has been attributed to endorphin release (beta-endorphin binding central opioid receptors) but is now understood to involve primarily endocannabinoid release (anandamide, a natural cannabis-like compound) that crosses the blood-brain barrier more effectively than beta-endorphins and activates CB1 receptors producing the anxiolytic, analgesic, and euphoric effects. The endocannabinoid response is specifically triggered by moderate-intensity sustained aerobic exercise.
Role
The endocannabinoid basis of exercise-induced euphoria provides the most compelling neurochemical explanation for why some people find aerobic exercise intrinsically rewarding — and why this reward is dose-dependent on exercise intensity and duration in ways that predict adherence. The person who discovers that moderate-intensity sustained aerobic exercise produces a natural endocannabinoid response has found a sustainable behavioral motivation that requires no external incentive structure — unlike high-intensity exercise or strength training, which do not reliably produce the same endocannabinoid response. Exercise modality matching to the specific neurochemical reward profile of the individual is an underused strategy for building sustainable exercise motivation.